Oppenheimer J H, Bernstein G, Surks M I
J Clin Invest. 1968 Jun;47(6):1399-406. doi: 10.1172/JCI105831.
Administration of phenobarbital to rats in a dosage schedule previously demonstrated to increase hepatocellular binding of thyroxine results in increased hormonal turnover, due both to increased deiodination and to fecal disposition of thyroxine iodine. The rate of biliary excretion of thyroxine iodine is roughly proportional to the hepatic content of exchangeable thyroxine. The enhanced peripheral disposition of thyroxine appears to lead to increased thyroidal function, as measured by isotopic iodine studies, and the maintenance of a normal nonradioactive serum PBI. On the other hand, thyroidectomized animals maintained on a constant replacement dose of L-thyroxine and treated with phenobarbital exhibit a marked fall in serum PBI. These findings suggest that increased thyroxine flux in phenobarbital-treated animals is secondary to primary stimulation of hepatocellular binding. Exchangeable intracellular thyroxine may thus be an important determinant of hormone turnover and, possibly, of hormonal action.
按照先前证明可增加甲状腺素肝细胞结合的剂量方案给大鼠施用苯巴比妥,会导致激素周转增加,这是由于脱碘增加以及甲状腺素碘的粪便排泄所致。甲状腺素碘的胆汁排泄速率大致与可交换甲状腺素的肝脏含量成正比。通过同位素碘研究测量,甲状腺素在外周的处置增强似乎导致甲状腺功能增加,并维持正常的非放射性血清蛋白结合碘(PBI)。另一方面,用恒定替代剂量的L-甲状腺素维持并接受苯巴比妥治疗的甲状腺切除动物,其血清PBI显著下降。这些发现表明,苯巴比妥处理的动物中甲状腺素通量增加是肝细胞结合受到原发性刺激的继发结果。因此,可交换的细胞内甲状腺素可能是激素周转以及可能的激素作用的重要决定因素。